Sunzen Biotech Bhd (0148) — Financial Flexibility Index
Sunzen Biotech Bhd (0148) has a Financial Flexibility Index of 0.22x as of September 2023. Free cash flow of RM3.67 Million (operating CF RM3.58 Million minus capex RM95.00K) represents 0% of total liabilities (RM16.55 Million). Check 0148 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sunzen Biotech Bhd Financial Flexibility Index (2016–2023)
Historical Financial Flexibility Index trend for Sunzen Biotech Bhd across 8 annual periods. See 0148 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sunzen Biotech Bhd (2016–2023)
Year-by-year free cash flow to debt coverage for Sunzen Biotech Bhd. For the full company profile including market capitalisation, see 0148 market cap overview.
| Year | Flexibility Index | Free Cash Flow (MYR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.09x | RM1.83 Million | RM819.39K | RM20.51 Million | ▲ +108.8% |
| 2022 | -1.02x | RM-29.59 Million | RM-32.06 Million | RM29.08 Million | ▼ -123.2% |
| 2021 | -0.46x | RM-13.96 Million | RM-16.36 Million | RM30.61 Million | ▼ -294.8% |
| 2020 | 0.23x | RM8.36 Million | RM7.20 Million | RM35.73 Million | ▲ +223.2% |
| 2019 | -0.19x | RM-7.02 Million | RM-11.05 Million | RM36.96 Million | ▼ -262.3% |
| 2018 | -0.05x | RM-2.13 Million | RM-4.07 Million | RM40.63 Million | ▼ -113.9% |
| 2017 | 0.38x | RM7.44 Million | RM4.02 Million | RM19.70 Million | ▼ -50.8% |
| 2016 | 0.77x | RM6.89 Million | RM256.13K | RM8.98 Million | — |